Evidence map›Paper›PMID 38561968›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Biomimetic Chiral Nanomaterials with Selective Catalysis Activity.

Honghui Cao, En Yang, Yoonseob Kim, Yuan Zhao, Wei Ma

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Chiral FeBioactive materials · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Biosynthesized Gold Nanoparticles fromAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Chirality in Transition Metal Dichalcogenide Nanostructures.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Biomimetic Chiral Nanomaterials with Selective Catalysis Activity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Honghui CaoSchool of Perfume and Aroma Technology, Shanghai Institute of Technology, No. 100 Haiquan Road, Shanghai, 201418, China.
En YangSchool of Food Science and Technology, State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, 214122, China.
Yoonseob KimDepartment of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong SAR, 999077, China.
Yuan ZhaoKey Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi, Jiangsu, 214122, China.ORCID 0000-0002-5937-1952
Wei MaSchool of Food Science and Technology, State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, 214122, China.ORCID 0000-0002-1278-9235

Funding

Fundamental Research Funds for the Central Universities JUSRP622018Key Research and Development Special Project of Gao'an City, Jiangxi Province, China 2023ZDYFZX06National Natural Science Foundation of China 22272065Natural Science Foundation of Jiangsu Province BK20211530
6 · The paper itself

Abstract

Chiral nanomaterials with unique chiral configurations and biocompatible ligands have been booming over the past decade for their interesting chiroptical effect, unique catalytical activity, and related bioapplications. The catalytic activity and selectivity of chiral nanomaterials have emerged as important topics, that can be potentially controlled and optimized by the rational biochemical design of nanomaterials. In this review, chiral nanomaterials synthesis, composition, and catalytic performances of different biohybrid chiral nanomaterials are discussed. The construction of chiral nanomaterials with multiscale chiral geometries along with the underlying principles for enhancing chiroptical responses are highlighted. Various biochemical approaches to regulate the selectivity and catalytic activity of chiral nanomaterials for biocatalysis are also summarized. Furthermore, attention is paid to specific chiral ligands, materials compositions, structure characteristics, and so on for introducing selective catalytic activities of representative chiral nanomaterials, with emphasis on substrates including small molecules, biological macromolecule, and in-site catalysis in living systems. Promising progress has also been emphasized in chiral nanomaterials featuring structural versatility and improved chiral responses that gave rise to unprecedented chances to utilize light for biocatalytic applications. In summary, the challenges, future trends, and prospects associated with chiral nanomaterials for catalysis are comprehensively proposed.

Indexed as

NanostructuresBiocatalysisBiomimetic MaterialsBiomimeticsCatalysisStereoisomerismbiomimetic nanomaterialschiroptical effectsselective catalysis activity

Identifiers

PMID38561968
PMCPMC11187969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.